309. Rumessen JJ. Serologisk screening for cøliaki. Ugeskr Læger 2004; 166: 2142–4
310. Sategna-Guidetti C, Pulitano R, Grosso S, Ferfoglia G. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 1993; 17: 123–27
311. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517–2524
312. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 152: 168–9
313. Valdimarsson T, Toss G, Ross I, Lofman O, Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–61
314. Scotta MS, Salvatore S, Salvatoni A, et al. Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol 1997; 92: 1331–34
315. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330–54
316. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol 2007; 42: 171–8
317. Løvik A, Lundin KEA. «Kostbehandling av cøliaki og dermatitis herpetiformis». Tidsskr Nor Lægeforen 2003; 123: 3237–40
318. Johnson D. Novel Drug for Celiac Disease Reduces GI and Non-GI Symptoms. Digestive Disease Week (DDW) 2014. Abstract 929f. Presented May 7, 2014. http://www.medscape.com/viewarticle/824778?sr…
319. Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol. Rep. (2015) 3 (1): 3–11
320. Ilus T, Kaukinen K, Virta LJ, et al. Incidence of malignancies in diagnosed celiac patients. Am J Gastroenterol 2014; 109(9): 1471–77
321. Fickling WE, McFarlane XA, Bhalla AK, Robertson DAF. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med 2001; 77: 33–6
322. Farthing MJ, Edwards CR, Rees LH, Dawson AM. Male gonadal function in coeliac disease: 1 sexual dysfunction, infertility, and semen quality. Gut 1982; 23: 608–14
323. Thawani SP, Brannagan TH, Lebwohl B, et al. Risk of neuropathy among 28 232 patients with biopsy-verified Celiac disease. JAMA Neurology 2015. doi:10.1001/jamaneurol. 2015.0475
324. Evans KE, Leeds JS, Morley S et.al. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci 2010; 55: 2999–3004
325. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215–18
326. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356–61
327. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566–72
328. Sultan AA, Tata LJ, Fleming KM, et al. Pregnancy complications and adverse birth outcomes among women with celiac disease. Am J Gastroenterol. 2014;109:1653–1661
329. Fagrådet i Norsk Cøliakiforening. Retningslinjer – cøliaki. 2004
330. Vanuytsel, T; et al. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers 2013. 1 (5): e27321
331. Fasano, A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 91 (1): 151–75
332. Lammers, Karen M.; Lu, Ruliang; Brownley, Julie; Lu, Bao; Gerard, Craig; Thomas, Karen; Rallabhandi, Prasad; Shea-Donohue, Terez; Tamiz, Amir. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008. 135 (1): 194–204.e3
333. Visser, Jeroen; Rozing, Jan; Sapone, Anna; Lammers, Karen; Fasano, Alessio. «Tight Junctions, Intestinal Permeability, and Autoimmunity Celiac Disease and Type 1 Diabetes Paradigms». Annals of the New York Academy of Sciences 2009. 1165: 195–205
